These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 19047914)
21. Thyroid transcription factor-1 expression in colorectal adenocarcinomas. Dettmer M; Kim TE; Jung CK; Jung ES; Lee KY; Kang CS Pathol Res Pract; 2011 Nov; 207(11):686-90. PubMed ID: 22019009 [TBL] [Abstract][Full Text] [Related]
22. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens. Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039 [TBL] [Abstract][Full Text] [Related]
23. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas. Al-Zahrani IH Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor. Zhao C; Bratthauer GL; Barner R; Vang R Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194 [TBL] [Abstract][Full Text] [Related]
25. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases. Lau SK; Desrochers MJ; Luthringer DJ Mod Pathol; 2002 May; 15(5):538-42. PubMed ID: 12011259 [TBL] [Abstract][Full Text] [Related]
26. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Chang YL; Lee YC; Liao WY; Wu CT Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379 [TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic immunoreactivity for thyroid transcription factor-1 in hepatocellular carcinoma: a comparative immunohistochemical analysis of four commercial antibodies using a tissue array technique. Pan CC; Chen PC; Tsay SH; Chiang H Am J Clin Pathol; 2004 Mar; 121(3):343-9. PubMed ID: 15023038 [TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions. Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic Utility of Thyroid Transcription Factor-1 in Ovarian Carcinoma and Its Relationship With Clinicopathologic Prognostic Parameters. Hakim SA; Youssef NS Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):237-243. PubMed ID: 26657873 [TBL] [Abstract][Full Text] [Related]
30. Carcinomas of ovary and lung with clear cell features: can immunohistochemistry help in differential diagnosis? Howell NR; Zheng W; Cheng L; Tornos C; Kane P; Pearl M; Chalas E; Liang SX Int J Gynecol Pathol; 2007 Apr; 26(2):134-40. PubMed ID: 17413979 [TBL] [Abstract][Full Text] [Related]
31. Thyroid transcription factor 1: a marker for lung adenoarinoma in body cavity fluids. Gomez-Fernandez C; Jorda M; Delgado PI; Ganjei-Azar P Cancer; 2002 Oct; 96(5):289-93. PubMed ID: 12378596 [TBL] [Abstract][Full Text] [Related]
32. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary. Esheba GE; Pate LL; Longacre TA Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882 [TBL] [Abstract][Full Text] [Related]
33. Biomarker-assisted diagnosis of ovarian, cervical and pulmonary small cell carcinomas: the role of TTF-1, WT-1 and HPV analysis. Carlson JW; Nucci MR; Brodsky J; Crum CP; Hirsch MS Histopathology; 2007 Sep; 51(3):305-12. PubMed ID: 17727473 [TBL] [Abstract][Full Text] [Related]
34. Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis. Castellvi J; Garcia A; de la Torre J; Hernandez J; Gil A; Xercavins J; Ramón y Cajal S Hum Pathol; 2006 Jul; 37(7):883-9. PubMed ID: 16784989 [TBL] [Abstract][Full Text] [Related]
35. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Garin-Chesa P; Campbell I; Saigo PE; Lewis JL; Old LJ; Rettig WJ Am J Pathol; 1993 Feb; 142(2):557-67. PubMed ID: 8434649 [TBL] [Abstract][Full Text] [Related]
36. True cytokeratin 8/18 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study. Hsu JD; Yao CC; Lee MY; Kok LF; Wang PH; Tyan YS; Han CP Int J Gynecol Pathol; 2010 May; 29(3):282-9. PubMed ID: 20407331 [TBL] [Abstract][Full Text] [Related]
37. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations. Esheba GE; Longacre TA; Atkins KA; Higgins JP Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634 [TBL] [Abstract][Full Text] [Related]
38. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [TBL] [Abstract][Full Text] [Related]
39. Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution. Penman D; Downie I; Roberts F J Clin Pathol; 2006 Jun; 59(6):663-4. PubMed ID: 16731609 [TBL] [Abstract][Full Text] [Related]
40. Haymaker gene expression in malignant and normal gynecologic tissues. Borowsky ME; Das B; Axiotis CA; Malka ES; Abulafia O; Norin AJ J Histochem Cytochem; 2006 Jul; 54(7):753-61. PubMed ID: 16495475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]